ArticlePharmaceuticals (Basel, Switzerland)2024

Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.

Shaimaa Hamza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.